Similarly, in type 1 diabetes and inflammatory bowel disease, despite the role of IL6R in immune modulation, the effects of IL6Ri are likely moderated by other significant genetic or environmental factors, reducing its singular impact. The gene discussed is IL6R; the disease is type 1 diabetes mellitus.